We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
National reports and tool to support the monitoring of the direct and indirect impacts of COVID-19 on the population.
The MHRA is ready to provide any assistance for clinical trials applications submitted for COVID-19
Guidance on the ventilation of indoor spaces to reduce the spread of respiratory infections, including coronavirus (COVID-19).
On 18 March the Defence Secretary announced new measures to enable armed forces personnel to support public services in response to the coronavirus outbreak.
DHSC publications relating to COVID-19 treatments and clinical trials.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
Information on variants of the SARS-CoV-2 virus.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
There are different regulations which apply to devices and equipment including hand gels and PPE (personal protective equipment)
This Directorate Children and Young People (DCYP) COVID-19 page provides important advice and updates for service parents.
Information on COVID-19 reinfection surveillance programme in England.
Guidance relating to blood clotting, myocarditis and Guillain-Barré Syndrome (GBS) after COVID-19 vaccination.
Find information on COVID-19, including guidance and support.
Guidance for EU Settlement Scheme applicants in or outside the UK who have been affected by restrictions associated with coronavirus.
Actions that trial sponsors should consider to build resilience into clinical trial design
The latest reproduction number (R) and growth rate of coronavirus (COVID-19).
An overview of the government's approach to managing local coronavirus (COVID-19) outbreaks.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).